To Augment or Not to Augment Consolidation Therapy for High-Risk Childhood Acute Lymphoblastic Leukemia

To Augment or Not to Augment Consolidation Therapy for High-Risk Childhood Acute Lymphoblastic Leukemia

Saved in:

Bibliographic Details
Main Author:	Shyam Srinivasan
Format:	Article
Language:	English
Published:	Thieme Medical and Scientific Publishers Pvt. Ltd. 2024-02-01
Series:	Indian Journal of Medical and Paediatric Oncology
Online Access:	http://www.thieme-connect.de/DOI/DOI?10.1055/s-0043-1774778
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

DYNAMIC BALANCE EVALUATION IN CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA UNDERGOING CONSOLIDATION THERAPY
by: Fulya Ipek-Erdem, et al.
Published: (2025-07-01)

Drug-Induced Liver Injury during Consolidation Therapy in Childhood Acute Lymphoblastic Leukemia as Assessed for Causality Using the Updated RUCAM
by: Fu-Li Qin, et al.
Published: (2022-01-01)

Relapsed childhood T-cell acute lymphoblastic leukemia and lymphoblastic lymphoma
by: Andrew D. Hughes, et al.
Published: (2025-01-01)

FocusAugMix: A data augmentation method for enhancing Acute Lymphoblastic Leukemia classification
by: Tanzilal Mustaqim, et al.
Published: (2025-06-01)

Comparative treatment costs of risk‐stratified therapy for childhood acute lymphoblastic leukemia in India
by: Tushar Mungle, et al.
Published: (2023-02-01)

A comprehensive consolidation of data on the connection between CDKN2A polymorphisms and the susceptibility to childhood acute lymphoblastic leukemia
by: Maryam Aghasipour, et al.
Published: (2024-12-01)

Isolated splenomegaly during remission in childhood acute lymphoblastic leukemia
by: S Ozsoylu, et al.
Published: (1985-10-01)

Bone mineral density in survivors of childhood acute lymphoblastic leukemia
by: Fani Athanassiadou, et al.
Published: (2006-04-01)

The efficacy of bortezomib during induction therapy in patients with high-risk acute lymphoblastic leukemia
by: Camila Terreros-Palacios, et al.
Published: (2025-07-01)

Leukemia-associated immunophenotype of tumor cells in childhood B-precursors acute lymphoblastic leukemia
by: L. V. Movchan
Published: (2014-07-01)

Association Between Maternal Diet During Pregnancy and the Risk of Childhood Acute Lymphoblastic Leukemia. An Overview
by: Kathya Torres‐Duarte, et al.
Published: (2025-06-01)

Investigating CD99 Expression in Leukemia Propagating Cells in Childhood T Cell Acute Lymphoblastic Leukemia.
by: Charlotte V Cox, et al.
Published: (2016-01-01)

Curing using the minimal – Strategies for treatment reduction in childhood acute lymphoblastic leukemia
by: Bernice LZ Oh, et al.
Published: (2025-06-01)

Causes of Death in Childhood Acute Lymphoblastic Leukemia: A Single-Center Experience
by: Matej Jelić, et al.
Published: (2025-06-01)

Late-effects of Chemoradiotherapy on Growth and Puberty in Survivors of Childhood Acute Lymphoblastic Leukemia
by: Sevgi Bilgiç Eltan, et al.
Published: (2022-12-01)

CURRENT STRATEGIES FOR THE DETECTION OF MINIMAL RESIDUAL DISEASE IN CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA
by: Juliana Maria Camargos Rocha, et al.
Published: (2016-04-01)

A rare metabolic complication of acute lymphoblastic leukemia in childhood: lactic acidosis
by: Müge Gökçe, et al.
Published: (2012-02-01)

HETEROGENEITY OF CHILDHOOD B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (EGIL SUBTYPE BIV)
by: I. A. Demina, et al.
Published: (2018-02-01)

Nanodrug Delivery Systems for Acute Lymphoblastic Leukemia Therapy
by: Aiyun Yang, et al.
Published: (2025-04-01)

Acute lymphoblastic leukemia and toxoplasmosis
by: G Hiçsönmez, et al.
Published: (1979-01-01)

Acute lymphoblastic leukemia in infants
by: Aytemiz Gürgey, et al.
Published: (2004-04-01)

Acute lymphoblastic leukemia in children
by: M. A. Maschan, et al.
Published: (2022-11-01)

Genomic landscape of childhood acute lymphoblastic leukemia in Malaysia: insights from array-CGH
by: Azli Ismail, et al.
Published: (2025-03-01)

5q deletion in childhood T-acute lymphoblastic leukemia at diagnosis: a case report
by: Yousra Sbibih, et al.
Published: (2025-06-01)

Therapeutic drug monitoring in the treatment of childhood acute lymphoblastic leukemia – A practical guideline
by: Miguel Vieira Martins, et al.
Published: (2025-06-01)

Association of <i>DROSHA</i> Variants with Susceptibility and Outcomes in Childhood Acute Lymphoblastic Leukemia
by: Ioannis Kyriakidis, et al.
Published: (2025-06-01)

Five-Year survival rate and the factors for risk-directed therapy in acute lymphoblastic leukemia
by: Bibin Varghese, et al.
Published: (2018-01-01)

Absence of Association between CCR5 rs333 Polymorphism and Childhood Acute Lymphoblastic Leukemia
by: Carlos Eduardo Coral de Oliveira, et al.
Published: (2014-01-01)

Health-related quality of life in long-term survivors of relapsed childhood acute lymphoblastic leukemia.
by: Stefan Essig, et al.
Published: (2012-01-01)

Living on a farm, contact with farm animals and pets, and childhood acute lymphoblastic leukemia: pooled and meta‐analyses from the Childhood Leukemia International Consortium
by: Laurent Orsi, et al.
Published: (2018-06-01)

Asparaginase-associated pancreatitis during therapy for pediatric acute lymphoblastic leukemia
by: M. Beth McCarville, et al.
Published: (2025-08-01)

T-cell dysfunction during blinatumomab therapy in pediatric acute lymphoblastic leukemia
by: Julie Ma, et al.
Published: (2025-08-01)

Cerebral aspergillus infection in pediatric acute lymphoblastic leukemia induction therapy
by: Gaurav Prakash, et al.
Published: (2012-01-01)

Bortezomib Combination Therapy of Relapsed and Refractory Acute Lymphoblastic Leukemia in Children
by: NA Batmanova, et al.
Published: (2017-07-01)

Synchronous childhood T-lymphoblastic lymphoma and B-cell precursor acute lymphoblastic leukemia associated with constitutional MMR deficiency syndrome –a case report
by: Joanna Bulsa, et al.
Published: (2025-05-01)

A systematic review of long-term cardiotoxic effects of treatment in survivors of childhood acute lymphoblastic leukemia
by: Paige Johnson, et al.
Published: (2025-07-01)

Genetic instability in HSPC subpopulations of umbilical cord blood from patients with childhood acute lymphoblastic leukemia
by: Katarina Vrobelova, et al.
Published: (2025-03-01)

Symptom diagnosis interval in childhood acute lymphoblastic leukemia: Prognostic impact and association with clinico-demographic factors
by: Ketan P Kulkarni, et al.
Published: (2012-01-01)

RUSSIAN-BELARUSIAN MULTICENTER GROUP STANDARD GUIDELINES FOR CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA FLOW CYTOMETRIC DIAGNOSTICS
by: I. A. Novikova, et al.
Published: (2018-05-01)

Blinatumomab in pediatric B-acute lymphoblastic leukemia
by: Yifang Cheng, et al.
Published: (2025-07-01)